- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01130233
Randomized Trial on Robotic Assisted Resection for Rectal Cancer
Randomized Controlled Trial Comparing the Bladder and Sexual Functions of Patients Who Undergo Laparoscopic and Robotic Assisted Resection for Rectal Cancer
Hypothesis: the bladder and sexual functions can be better preserved in patients with robotic assisted rectal surgery
This is a randomized trial comparing the bladder and sexual function of patients who undergo laparoscopic and robotic assisted rectal resection for rectal cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a randomized trial comparing the bladder and sexual function of patients who undergo laparoscopic and robotic assisted rectal resection for rectal cancer
The primary objective of this study is to compare the bladder and sexual functions of patients who undergo laparoscopic and robotic assisted resection for rectal cancer through a randomized controlled trial.
The secondary outcome measures include
- The operative outcome in terms of the complication rate, hospital stay and reoperation of the two groups;
- The quality of life of the patients and the cost of the two groups
- The quality of the resected specimens
- The local recurrence rates at two years after the surgery
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Queen Mary Hospital
-
Contact:
- Wai Lun LAW, MBBS, MS
- Phone Number: +852 22554763
- Email: lawwl@hkucc.hku.hk
-
Principal Investigator:
- Wai Lun Law, MBBS, MS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Histologically proven new case of rectal cancer with the lower border within 15 cm from anal verge
- Age >18 years
- Informed consent obtained
- American Society of Anesthesiologist class 1-3
- No contraindication to laparoscopic surgery
- Acceptable operating risk
Exclusion Criteria:
- Locally advanced fixed tumor with the need for exenterative surgery
- Severe cardiac or pulmonary comorbidity rendering pneumoperitoneum hazardous
- Multiple previous operations with the anticipation of dense peritoneal adhesions
- No informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: robotic
robotic assisted rectal resection
|
robotic assisted rectal resection
|
|
Active Comparator: laparoscopic
laparoscopic rectal resection
|
laparoscopic rectal resection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bladder function
Time Frame: one year
|
Urodynamic Questionnaire
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
tumor status
Time Frame: One year
|
recurrence and survival
|
One year
|
|
Quality of life
Time Frame: one year
|
Questionnaire
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Wai Lun Law, MBBS, MS, The University of Hong Kong
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW 09-132
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.